☰
🏠
📞  +353 1 6643768
 
📧  info@medaval.ie
      
LifeScan OneTouch Verio (V2)
Device Name:
OneTouch Verio (V2)
Manufacturer:
Johnson & Johnson, 1 Johnson & Johnson Plaza, New Brunswick, New Jersey 08933, UNITED STATES.
Measuring functions:
Blood glucose
Primary Client Use:
Intended for self-measurement and home use
Measurement Site:
Finger
Measurement Occurrence:
Single measurements only
Availability:
Available Currently
Description:
The LifeScan OneTouch Verio (V2) is an automatic blood glucose meter. The accuracy of its blood glucose measurement technology has yet to be proven to MDR requirements. Blood glucose measurements are taken from the finger. It is intended for self-measurement and home use.
Assessment:
While the technology used in the LifeScan OneTouch Verio (V2), to measure blood glucose, has been assessed, the results of the study have not been published and cannot be verified.
Recommendations:
Accuracy AssessmentRecommendationBasis
BG Medaval None While a clinical validation is claimed, it cannot be checked properly.
BG Institute of Health Economics (CA) General use No evidence provided
Relevant Publications:

Katz LB, Grady M, Setford J, Levy BL. OneTouch Blood Glucose Monitoring Systems – Impact of New Technologies on the Efficacy of Self-monitoring Blood Glucose US Endocrinology. 2018 Jan;14(Suppl 1):2-8. Epub: 2018 Jan 22. Available from: www.touchendocrinology.com.

Given the struggles that many patients have with ongoing adherence, motivation, health literacy and/or numeracy, the newer BGMS features described in this article represent important tools which may help HCPs better communicate with their patients on how to both understand their BG data and encourage appropriate self-management from their patients.

Grady M, Katz LB, Levy BL. Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients With Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study). J Diabetes Sci Technol. 2018 Nov;12(6):1211-1219. Epub: 2018 May 31. doi: 10.1177/1932296818775755. PMID: 29848106. Available from: PMC6232745.

Switching patients to BGMs featuring a CRI resulted in improvements in glycemic control compared to subjects using currently marketed BGMs that do not use a CRI. See: J Diabetes Sci Technol. 2018 Nov;12(6):1220-1222.

Macleod K, Katz LB, Cameron H. Capillary and Venous Blood Glucose Accuracy in Blood Glucose Meters Versus Reference Standards: The Impact of Study Design on Accuracy Evaluations. J Diabetes Sci Technol. 2019 May;13(3):546-552. Epub: 2018 Aug 7. doi: 10.1177/1932296818790228. PMID: 30084263. Available from: PMC6501528.

Deviations from the best practice study design of comparing capillary blood glucose results tested on the blood glucose meter with the manufacturer’s stated reference instrument will affect accuracy of blood glucose measurements. See: J Diabetes Sci Technol. 2019 May;13(3):553-558.

Drincic AT. Analysis of "Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control and Patients With Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study)". J Diabetes Sci Technol. 2018 Nov;12(6):1220-1222. Epub: 2018 Aug 10. doi: 10.1177/1932296818793115. PMID: 30095006. Available from: PMC6232752.

See: J Diabetes Sci Technol. 2018 Nov;12(6):1211-1219.

Thorpe GH. Analysis of "Capillary and Venous Blood Glucose Accuracy in Blood Glucose Meters Versus Reference Standards: The Impact of Study Design on Accuracy Evaluations". J Diabetes Sci Technol. 2019 May;13(3):553-558. Epub: 2018 Sep 15. doi: 10.1177/1932296818799365. PMID: 30222000. Available from: PMC6501518.

See: J Diabetes Sci Technol. 2019 May;13(3):546-552.

Krouwer JS. Why the Details of Glucose Meter Evaluations Matters. J Diabetes Sci Technol. 2019 May;13(3):559-560. Epub: 2018 Oct 17. doi: 10.1177/1932296818803113. PMID: 30328716. Available from: PMC6501532. Comment to: J Diabetes Sci Technol. 2019 May;13(3):546-552.

The publication is a letter or correspondence in which the LifeScan OneTouch Verio (V2) is referenced.

Fritzen K, Basinska K, Stautner C, Braun KF, Rubio-Almanza M, Nicolucci A, Kennon B, Vergès B, Hosny Y, Schnell O. Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems. J Diabetes Sci Technol. 2020 Mar;14(2):262-270. Epub: 2019 Aug 6. doi: 10.1177/1932296819864665. PMID: 31387385. Available from: PMC7196878.

Improving metabolic control in patients with diabetes by the utilization of CRI-based GMs may have substantial positive effects on the expenditure of the healthcare systems of several European countries.

© Medaval Ltd. Please read the Terms and Conditions before using this site.